Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2173630Generated: October 31, 2026

5-(Chloromethyl)-3-methyl-1,2,4-oxadiazole → 5-tert-Butyl-3-(3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine

https://huagongshe.com/reaction/2173630

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-(Chloromethyl)-3-methyl-1,2,4-oxadiazoleHCID 12774825—
Reactant5-tert-Butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 71558205—
ReactantHCID 178441781HCID 178441781—
Product5-tert-Butyl-3-(3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 86683357—

Reaction Steps

In analogy to the procedure described for the synthesis of 5-tert-butyl-7-(3,3-difluoropyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 61), the title compound was prepared from 5-tert-Butyl-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and 5-(chloromethyl)-3-methyl-1,2,4-oxadiazole and isolated as light-red solid. MS(m/e): 371.2 (MH+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09056866B2
Source datasetuspto-grants-2015_06
ORD IDord-0c2ffe200ef743f3a74b53ec4f719b64
Source noteuspto-grants-2015_06